(Q29619608)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

main subject

Dengue virus

1 reference

17558424

dengue vaccine

1 reference

17558424

dengue fever

1 reference

4

Murphy BR

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

author name string

Whitehead SS

series ordinal

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

Blaney JE

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

Durbin AP

series ordinal

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

1 reference

https://s100.copyright.com/AppDispatchServlet?title=Prospects for a dengue virus vaccine&author=Stephen S. Whitehead et al

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

publication date

July 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

Nature Reviews Microbiology

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

volume

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

issue

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

page(s)

518-28

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

30 April 2017

copyright license

no value

1 reference

https://s100.copyright.com/AppDispatchServlet?title=Prospects for a dengue virus vaccine&author=Stephen S. Whitehead et al

copyright status

copyrighted

1 reference

https://s100.copyright.com/AppDispatchServlet?title=Prospects for a dengue virus vaccine&author=Stephen S. Whitehead et al

cites work

Dengue fever, Hawaii, 2001-2002

1 reference

Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored

21 January 2018

1 reference

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

21 January 2018

1 reference

The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers.

21 January 2018

1 reference

rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naïve adults.

21 January 2018

1 reference

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys

21 January 2018

1 reference

Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations

21 January 2018

1 reference

Dengue epidemiology: virus epidemiology, ecology, and emergence

21 January 2018

1 reference

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

31 March 2020

1 reference

Dengue and dengue hemorrhagic fever

31 March 2020

1 reference

Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand

31 March 2020

1 reference

Epidemiologic studies on Dengue in Santiago de Cuba, 1997.

31 March 2020

1 reference

A prospective study of dengue infections in Bangkok

31 March 2020

1 reference

Research on dengue during World War II

31 March 2020

1 reference

Dengue and chikungunya virus infection in man in Thailand, 1962-1964. II. Observations on disease in outpatients

31 March 2020

1 reference

Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization

31 March 2020

1 reference

Dengue and chikungunya virus infection in man in Thailand, 1962-1964. IV. Epidemiologic studies in the Bangkok metropolitan area

31 March 2020

1 reference

Early Clinical and Laboratory Indicators of Acute Dengue Illness

31 March 2020

1 reference

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

31 March 2020

1 reference

Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia

31 March 2020

1 reference

Ultrasound findings in dengue haemorrhagic fever

31 March 2020

1 reference

Role of ultrasound in dengue fever

31 March 2020

1 reference

Dengue hemorrhagic fever and fulminant hepatic failure

31 March 2020

1 reference

Unusual neurologic manifestations occurring during dengue fever infection.

31 March 2020

1 reference

Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand

31 March 2020

1 reference

Etiologies of the Experimental Dengues of Siler and Simmons *

31 March 2020

1 reference

Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge

31 March 2020

1 reference

Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion

31 March 2020

1 reference

Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity

31 March 2020

1 reference

Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children

31 March 2020

1 reference

Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.

31 March 2020

1 reference

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

31 March 2020

1 reference

Monoclonal Antibody Mapping of the Envelope Glycoprotein of the Dengue 2 Virus, Jamaica

31 March 2020

1 reference

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys

31 March 2020

1 reference

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

31 March 2020

1 reference

A variant in the CD209 promoter is associated with severity of dengue disease

31 March 2020

1 reference

TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients

31 March 2020

1 reference

Neutralization and antibody-dependent enhancement of dengue viruses

31 March 2020

1 reference

Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles

31 March 2020

1 reference

Immunopathological mechanisms in dengue and dengue hemorrhagic fever

31 March 2020

1 reference

Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement

31 March 2020

1 reference

Development of a live attenuated dengue virus vaccine using reverse genetics

31 March 2020

1 reference

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

31 March 2020

1 reference

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

31 March 2020

1 reference

Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.

31 March 2020

1 reference

Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3

31 March 2020

1 reference

Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3).

31 March 2020

1 reference

A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

31 March 2020

1 reference

Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2

31 March 2020

1 reference

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

31 March 2020

1 reference

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

31 March 2020

1 reference

A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.

31 March 2020

1 reference

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys

31 March 2020

1 reference

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

31 March 2020

1 reference

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

31 March 2020

1 reference

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

31 March 2020

1 reference

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

31 March 2020

1 reference

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

31 March 2020

1 reference

Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys

31 March 2020

1 reference

The WHO dengue classification and case definitions: time for a reassessment

31 March 2020

1 reference

RNA Secondary Structure in the Coding Region of Dengue Virus Type 2 Directs Translation Start Codon Selection and Is Required for Viral Replication

31 March 2020

1 reference

A structural perspective of the flavivirus life cycle

31 March 2020

1 reference

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

31 March 2020

1 reference

Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection

31 March 2020

1 reference

Antibodies from patients with dengue viral infection mediate cellular cytotoxicity

31 March 2020

1 reference

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

31 March 2020

1 reference

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

31 March 2020

1 reference

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

31 March 2020

1 reference

Sylvatic transmission of arboviruses among Bornean orangutans

31 March 2020

1 reference

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

31 March 2020

1 reference

Impact of dengue/dengue hemorrhagic fever on the developing world

31 March 2020

1 reference

7 January 2021

An epidemic of dengue on Tahiti associated with hemorrhagic manifestations *

1 reference

7 January 2021

Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases

1 reference

7 January 2021

Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study

1 reference

7 January 2021

Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants

1 reference

7 January 2021

Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection

1 reference

7 January 2021

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1014054283

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17558424

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017